Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. 

Biotechnology

Prelude Therapeutics

Prelude Therapeutics' headquarters in Wilmington, DE, United States

Kris Vaddi

Peggy Scherle

Aimee Crombie

Jane H.

Jane Huang

Bryant Lim

Michele Porreca

Julian C. Baker

Martin Babler

Paul A. Friedman

David Bonita

Victor Sandor

The Research and Development team at Prelude Therapeutics focuses on discovering and developing innovative drug candidates targeting critical cancer cell pathways. Comprising scientists and researchers across various specializations—including biology, biochemistry, medicinal chemistry, and informatics—the team conducts cutting-edge research to identify new therapeutic targets, optimize lead compounds, and advance promising candidates through preclinical and clinical development stages. Their collaborative efforts aim to bring transformative cancer treatments from the lab to the clinic.

Research and Development

The Science & Research team at Prelude Therapeutics is responsible for discovering and developing novel drug candidates that target essential cancer cell pathways. Comprising experts in chemistry, biology, drug discovery, translational research, and process chemistry, the team collaborates to advance the company's precision oncology pipeline from conceptualization through clinical development.

Science & Research

The Clinical Development Team at Prelude Therapeutics oversees the design, implementation, and management of clinical trials for innovative drug candidates. They ensure regulatory compliance, analyze clinical data, and collaborate with cross-functional teams to advance precision oncology therapies from conception through clinical evaluation.

Clinical Development Team

The Leadership Team at Prelude Therapeutics is responsible for setting the strategic direction and operational oversight of the company. They leverage their diverse expertise in chemistry, science, technical operations, and human resources to guide the development of innovative oncology drug candidates and ensure alignment with the company’s mission of targeting critical cancer pathways. Through collaboration and strategic planning, the team drives initiatives that foster growth, streamline operations, and enhance the company's impact in the precision oncology landscape.

Leadership Team

The Medical and Clinical Operations team at Prelude Therapeutics oversees the strategic planning, execution, and management of clinical trials. They ensure seamless coordination between clinical research and patient engagement to drive the development of innovative cancer therapies.

Medical and Clinical Operations

The Regulatory and Operations Team at Prelude Therapeutics ensures compliance with industry regulations, manages regulatory submissions, oversees lab and facility operations, and drives strategic planning to support the clinical development of precision oncology drugs.

Prelude Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Science & Research

Clinical Development Team

Leadership Team

Medical and Clinical Operations

Regulatory and Operations Team

Offices

Prelude Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Science & Research

Clinical Development Team

Leadership Team

Medical and Clinical Operations

Regulatory and Operations Team

Offices

Related companies